DSIP 5mg

Delta Sleep-Inducing Peptide (DSIP) is a synthetic nonapeptide originally characterized by the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It has been widely studied for its structural and biochemical properties in vitro, offering potential utility in peptide interaction modeling, phosphorylation signal simulations, and other molecular-level assays. Its relatively small size and hydrophilic profile make it a candidate for synthetic peptide mapping and controlled bioanalytical research.

Peptide Stability and Molecular Dynamics

In vitro, DSIP demonstrates moderate stability under neutral pH conditions and is suitable for use in various buffered environments. Though susceptible to enzymatic degradation in biological fluids, DSIP maintains sufficient integrity in isolated, sterile conditions such as peptide binding assays and biochemical simulations. Its conformation in aqueous systems allows for reproducibility in structure-function evaluations and phospho-peptide comparison studies.

Due to its solubility and compatibility with common solvents like sterile water and acetonitrile, DSIP is also used in high-performance liquid chromatography (HPLC) calibration and other purity assessment platforms. Structural analyses using circular dichroism or NMR spectroscopy have shown DSIP to exhibit flexible conformational behavior, useful in studying peptide-ligand interactions.

Applications in In Vitro Peptide Research

DSIP is utilized in in vitro research as a model peptide for exploring synthetic bioactivity, amino acid sequence behavior, and peptide-receptor analog development. It can be applied in cell-free biochemical systems such as peptide microarrays, phospho-protein signal simulations, or receptor-binding computational models where experimental peptides are analyzed for affinity, selectivity, or conformational shifts.

Further in vitro applications include use in fluorescence-based screening platforms, mass spectrometry peptide libraries, and ligand docking assays. Researchers may incorporate DSIP as a comparative control peptide in studies aimed at understanding amino acid contributions to binding efficiency or metabolic stability.

Research Use and Limitations

All research involving DSIP must remain strictly confined to in vitro laboratory experimentation. This includes peptide mapping, phosphorylation modeling, receptor binding simulations, and peptide interaction studies in synthetic or cell-free environments. DSIP is not intended for any form of biological or clinical research, and no biological activity is implied outside of controlled laboratory testing scenarios.

DSIP is provided solely for scientific investigation and must be handled according to standard laboratory safety protocols. Appropriate containment procedures, storage, and disposal practices must be observed at all times. Experimental data derived from in vitro environments should not be extrapolated beyond the synthetic model system in which they were generated.

Conclusion

DSIP serves as a valuable tool for in vitro scientific research, particularly within the fields of peptide chemistry and structural biochemistry. Its sequence-specific behavior, solubility profile, and compatibility with advanced molecular techniques make it suitable for studying synthetic pathways, post-translational modification analogs, and interaction screening systems. As a laboratory research reagent, DSIP continues to support peptide science through theoretical modeling and synthetic assay development.

References

1. Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006;97(2):303–309.
2. Schoenenberger GA. Characterization, properties, and multivariate functions of delta-sleep-inducing peptide (DSIP). Eur Neurol. 1984;23(5):321–345.
3. Iyer KS, Marks GA, Kastin AJ, McCann SM. Evidence for a role of delta sleep-inducing peptide in slow-wave sleep and sleep-related growth hormone release in the rat. Proc Natl Acad Sci USA. 1988;85(10):3653–3656.
4. Nakamura A, Nakashima M, Sugao T, et al. Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP). Eur J Pharmacol. 1988;155(3):247–253.
5. Iyer KS, McCann SM. Delta sleep-inducing peptide (DSIP) stimulates the release of LH but not FSH via a hypothalamic site of action in the rat. Brain Res Bull. 1987;19(5):535–538.

Important Notice

Although referenced studies may historically involve in vivo data, this content and the DSIP product are presented exclusively for in vitro laboratory use only. No reference to or endorsement of biological testing, human use, or animal use is made or implied.